Company Overview
American Healthcare Capital is pleased to introduce the largest provider of medical services for private-sector behavioral healthcare hospitals in Texas. The company’s team of family practice doctors, physician assistants, and nurse practitioners provide state-mandated history and physical assessments and medical follow-up care for 100% of patients in several behavioral health hospitals located in major metropolitan areas of Texas.
The company treats patients from a wide range of cultural and socioeconomic backgrounds and their practice is committed to providing the highest level of services to patients struggling with or in recovery from addiction or other psychiatric disorders. The practice has earned nationwide recognition in the medical and mental health treatment fields.
The practice is centrally managed from a single office, and all employees perform their job functions remotely. The company is also highly efficient in billing and collections and has existing insurance contracts with all major providers in the state of Texas, both in managed Medicare/Medicaid and private insurance. The practice averages 8,500 patient events per month. All referrals come through patients admitted to contracted hospitals.
Financial Overview
In 2022, total gross revenue was $3,372,178 with an adjusted EBITDA of $1,108,703. In 2023, the company’s gross revenue was $4,290,124 with an adjusted EBITDA of $1,301,974. The company achieved $5 million in gross revenue in 2024 with an adjusted EBITDA of $1,144,501 (due to front-loaded investments in operational infrastructure to support a major new hospital contract). The company closed 2025 with gross revenue of $7.2 million and adjusted EBITDA of $2,014,695.
In 2026, gross revenue is projected to increase to approximately $8.1 million with adjusted EBITDA of $2.7 million, driven by the full-year contribution of a new hospital contract in 2025 and additional revenue from several newly executed smaller hospital contracts, which are expected to begin generating revenue in the second half of 2026. Beyond this, there are ample opportunities for continued growth, both within the existing customer base, through expansion into additional vertical markets via telemedicine, and through further geographic expansion.
Staff Overview
All employees are expected to stay on under new management. The sellers are also available and open to staying on as consultants post-acquisition.
Asking Price
The sellers are seeking a valuation in the 6 – 8 times EBITDA range that take into consideration their projected growth and run rate for 2026.